Evidence map›Paper›PMID 35990680›Full record

ArticleFrontiers in immunology2022

LNA-anti-miR-150 alleviates renal interstitial fibrosis by reducing pro-inflammatory M1/M2 macrophage polarization.

Xiangnan Hao, Junjun Luan, Congcong Jiao, Cong Ma, Zixuan Feng, Lingzi Zhu, Yixiao Zhang, Jingqi Fu, Enyin Lai, Beiru Zhang and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Role of miRNAs in macrophage-mediated kidney injury.Pediatric nephrology (Berlin, Germany) · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Xiangnan HaoDepartment of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.
Junjun LuanDepartment of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.
Congcong JiaoDepartment of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.
Cong MaDepartment of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.
Zixuan FengDepartment of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.
Lingzi ZhuDepartment of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.
Yixiao ZhangDepartment of Urology, Shengjing Hospital of China Medical University, Shenyang, China.
Jingqi FuProgram of Environmental Toxicology, School of Public Health, China Medical University, Shenyang, China.
Enyin LaiDepartment of Physiology, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou, China.
Beiru ZhangDepartment of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.
Yanqiu WangDepartment of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.
Jeffrey B KoppKidney Disease Section, NIDDK/NIH, Bethesda, MD, United States.
Jingbo PiProgram of Environmental Toxicology, School of Public Health, China Medical University, Shenyang, China.
Hua ZhouDepartment of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.
China Medical University · CNNational Institutes of Health · USZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal interstitial fibrosis (RIF) is a common pathological feature contributing to chronic injury and maladaptive repair following acute kidney injury. Currently, there is no effective therapy for RIF. We have reported that locked nuclear acid (LNA)-anti-miR-150 antagonizes pro-fibrotic pathways in human renal tubular cells by regulating the suppressor of cytokine signal 1 (SOCS1)/Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway. In the present study, we aimed to clarify whether LNA-anti-miR-150 attenuates folic acid-induced RIF mice by regulating this pathway and by reducing pro-inflammatory M1/M2 macrophage polarization. We found that renal miR-150 was upregulated in folic acid-induced RIF mice at day 30 after injection. LNA-anti-miR-150 alleviated the degree of RIF, as shown by periodic acid-Schiff and Masson staining and by the expression of pro-fibrotic proteins, including alpha-smooth muscle actin and fibronectin. In RIF mice, SOCS1 was downregulated, and p-JAK1 and p-STAT1 were upregulated. LNA-anti-miR-150 reversed the changes in renal SOCS1, p-JAK1, and p-STAT1 expression. In addition, renal infiltration of total macrophages, pro-inflammatory M1 and M2 macrophages as well as their secreted cytokines were increased in RIF mice compared to control mice. Importantly, in folic acid-induced RIF mice, LNA-anti-miR-150 attenuated the renal infiltration of total macrophages and pro-inflammatory subsets, including M1 macrophages expressing CD11c and M2 macrophages expressing CD206. We conclude that the anti-renal fibrotic role of LNA-anti-miR-150 in folic acid-induced RIF mice may be mediated by reducing pro-inflammatory M1 and M2 macrophage polarization

Indexed as

Kidney DiseasesMicroRNAsAnimalsAntagomirsCytokinesFibrosisFolic AcidHumansMacrophagesMiceSuppressor of Cytokine Signaling ProteinsAntagomirsCytokinesFolic AcidMicroRNAsMIR150, humanSuppressor of Cytokine Signaling Proteinsfolic acidLNA-anti-miR-150M1/M2 macrophage polarizationrenal fibrosisSOCS1/JAK1/STAT1

Identifiers

PMID35990680
PMCPMC9389080
OpenAlexW4289861343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.